Position
Parallel Advisors, LLC in Denali Therapeutics Inc.
Back to the book · All holders of DNLI
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $963$16.51 → $19.20
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 358 | $5.91K | — | — | — | 0.0% |
| Q1 2026 | 358 | $6.87K | $19.20 | $963 | $0 | 0.0% |